Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Editor's note channel feed
Who are the women blazing trails in biopharma R&D? Nominate them for Endpoints' special report
7 years ago
Come join me during my round-the-world biotech adventure in October, with events in London and Shanghai — plus
7 years ago
The 10 most popular stories in Endpoints News — so far in 2017
8 years ago
Let the jousting begin: Which top biopharma companies are looking to make a splash at ASH?
8 years ago
R&D
We've taken a big step forward at Endpoints News — and with your help, we'll make more strides
8 years ago
The business model of Endpoints News — and why you should subscribe
8 years ago
Endpoints Insider: The world’s oldest new biotech pub ends its 12th month on a roll
9 years ago
Cheers! Endpoints News turns 1 today — and we're unwrapping info on a new subscription plan
9 years ago
The 10 most popular reports in Endpoints News — so far
9 years ago
What is Endpoints?
10 years ago
First page
Previous page
1
2
3